Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Introducing TIES™: A Foundational Men's Fertility and Performance Brand, Backed by $1.5M Seed Round Led by HumanCo and Jason H. Karp

TIES Logo Release

News provided by

HumanCo Investments

Apr 28, 2026, 09:13 ET

Share this article

Share toX

Share this article

Share toX

Built by a newlywed couple navigating the journey themselves, TIES exists to change how men think about their preconception health… where showing up for fatherhood starts before day one.

AUSTIN, Texas, April 28, 2026 /PRNewswire/ -- Men contribute to 50% of every fertility journey. Today, TIES™ launches to meet them there. The brand is announcing the launch of Foundations, a proactive men's fertility and performance supplement, alongside a $1.5M seed round led by HumanCo, the mission-driven health and wellness holding company founded by Jason H. Karp, who will join the TIES board of directors.

TIES Foundations - Launch Video
TIES Foundations - Launch Video
Speed
Speed

A Conversation Nobody is Having
According to a landmark review published in Human Reproduction Update, global sperm concentration has declined by approximately 50% from 1973 to 2018. Total sperm count has declined even more steeply by over 60% over the same period. The rate of decline in sperm concentration has also accelerated in recent decades, more than doubling from 1.16% per year to 2.64% per year post-2000 [1].

Men contribute to 50% of all infertility cases. TIES is built around that reality, giving men a brand that's proactive, science-backed, and approachable.

A Newlywed Couple's Founding Story Built Around the Gap
Co-Founders Luke and Camryn Novak, both former Division I athletes who have spent their lives approaching health with intention, built TIES out of a question Luke asked during their own family planning journey.

"When Camryn and I started talking about having a family, she began doing some baseline tests, checking in with her doctor, taking prenatals, and reading everything she could to best prepare," said Luke Novak, Co-Founder of TIES. "I watched all of that and just asked a simple question: is there anything I should be doing? When we started researching, we couldn't find anything that actually spoke to men in an approachable way, with ingredients and dosing built for how men's bodies actually work. That question is what TIES is built around. TIES is built for the man who shows up with intention in every area of his life. He deserves a brand that actually speaks to him, with a formulation built to match that standard."

"This was personal for us from day one," said Camryn Novak, Co-Founder of TIES. "We realized early on how much the fertility burden has been placed on women, even though men are half the equation. Luke and I went through this journey as a couple and made a commitment to build it the right way. That meant partnering with the best investors, the most credentialed doctors, and the highest quality manufacturers we could find. This is a product that we will use personally, along with our family and closest friends, and that responsibility shaped every single decision we made."

The Foundations Formula
Foundations was developed in collaboration with five leading physicians and specialists in reproductive medicine, integrative health, and preconception nutrition, and built by an experienced team of formulation scientists. Every ingredient is research-backed, third-party tested, and manufactured in an FDA-registered, cGMP-compliant facility.

The formula is built to support the core biological systems required for male fertility, including antioxidant defense, sperm and reproductive health, healthy hormone function, and men's overall health*.

Key research-backed ingredients include:

  • Vitamin C: Supports healthy sperm morphology, DNA integrity, and antioxidant protection2,3
  • CoQ10: Supports sperm motility through mitochondrial energy production, provides protection from oxidative stress, and helps support healthy sperm concentration2,4,5
  • Vitamin B12: Supports healthy sperm count, concentration, motility, and helps protect sperm DNA from oxidative stress6
  • L-Carnitine + Acetyl-L-Carnitine: Supports sperm motility, morphology, and mitochondrial function2,7,8
  • Zinc: Supports healthy sperm production, motility, and morphology9,10
  • Selenium: Supports healthy sperm development, motility and provides protection from oxidative stress2,11
  • Folate (L-5-Methyl-THF-Calcium): Supports sperm development, DNA health, integrity, and healthy homocysteine levels12,13

Foundations is available now at www.allourties.com

TIES Science Team
Foundations is formulated with input from a science team of five leading physicians and specialists in reproductive medicine, integrative health, and preconception nutrition.

"I have provided care to men with infertility for over 25 years. These men desire simple interventions that could support them in their fertility journey. The scientifically backed ingredients in TIES are designed to support an optimized genital tract environment, help protect sperm from oxidative stress, and promote overall sperm health.*" 

  • Peter Kolettis, MD, Male Infertility Specialist, Fellowship-Trained at the Cleveland Clinic

"Foundations is a really fantastic blend. The antioxidants are like little superheroes, protecting sperm from damage and supporting count, motility, and morphology. Fertility is an extremely energy-intensive process, and the carnitines and CoQ10 play a critical role in mitochondrial health. The methylated form of folate is ideal for how the body uses it in the DNA programming and building of sperm."

  • Brooke Boskovich, Functional Medicine Dietitian; Founder, The Fertility Dietitian; Specializing in Fertility Nutrition & Reproductive Health

Backed by the Best in Health and Wellness
HumanCo, the mission-driven health and wellness holding company founded by Jason H. Karp, has attracted some of the most respected names in health, wellness, and culture as investors, including Scarlett Johansson, Indra Nooyi (former CEO of PepsiCo), Walter Robb (former CEO of Whole Foods), Shawn Mendes, and Nick Jonas, among others.

"There hasn't really been a gold standard approach to proactively supporting men's fertility. Sperm health is a key biomarker, and men's fertility is a benchmark of overall health. TIES is taking an approach that is a new standard of bioavailability, rigorous third-party lab testing, and clinically-backed ingredients. Men's fertility is an area that has long been ignored, and TIES brings a sense of care and fanaticism that is in a class of its own."

  • Jason H. Karp, Founder & CEO, HumanCo

About TIES™
TIES is a foundational men's fertility and performance supplement brand, built around the belief that showing up for fatherhood starts before day one. Co-founded by husband-and-wife team Luke and Camryn Novak, TIES is a doctor-formulated brand developed alongside leading physicians, scientists, and researchers specializing in reproductive medicine, integrative health, and preconception nutrition. Formulated with clinically studied ingredients and held to rigorous third-party testing standards, TIES is setting a new bar for transparency and quality in men's wellness. TIES is headquartered in Austin, TX. Learn more at www.allourties.com and follow along at @allourties.

References

  1. Levine H, et al. Human Reproduction Update. 2023.
  2. Effect of Antioxidants on Sperm Quality Parameters in Subfertile Men: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. 2022 — China Academy of Chinese Medical Sciences
  3. The Effect of Vitamin C on the Gene Expression Profile of Sperm Protamines in the Male Partners of Couples with Recurrent Pregnancy Loss: A Randomized Clinical Trial. 2020 — Clinical and Experimental Reproductive Medicine
  4. Antioxidant Supplements and Semen Parameters: An Evidence-Based Review. 2017 — Iran University of Medical Sciences
  5. Coenzyme Q10 Treatment in Infertile Men with Idiopathic Asthenozoospermia: A Placebo-Controlled, Double-Blind Randomized Trial. 2009 — Polytechnic University of Marche, Italy
  6. Vitamin B12 and Semen Quality. 2017 — Jordan University of Science and Technology
  7. A Placebo-Controlled Double-Blind Randomized Trial of the Use of Combined L-Carnitine and L-Acetyl-Carnitine Treatment in Men with Asthenozoospermia. 2004 — Sapienza University of Rome, Italy
  8. The Effect of Antioxidants on Sperm Quality Parameters and Pregnancy Rates for Idiopathic Male Infertility: A Network Meta-Analysis of Randomized Controlled Trials. 2022 — Frontiers in Endocrinology
  9. Zinc is an Essential Element for Male Fertility: A Review of Zn Roles in Men's Health, Germination, Sperm Quality, and Fertilization. 2018 — Journal of Reproduction and Infertility
  10. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis. 2016 — Scientific Reports: Nature
  11. The Effects of Oral Antioxidants on the Semen of Men with Idiopathic Oligoasthenoteratozoospermia. 2018 — Clinical and Experimental Reproductive Medicine
  12. MTHFR Isoform Carriers: 5-MTHF vs Folic Acid — A Key to Pregnancy Outcome. 2018 — Journal of Assisted Reproduction and Genetics
  13. Hyperhomocysteinemia in Hypofertile Male Patients Can Be Alleviated by Supplementation with 5-MTHF Associated with One Carbon Cycle Support. 2023 — Frontiers in Reproductive Health
  14. Link to Ingredient Overview Here

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE HumanCo Investments

21%

more press release views with 
Request a Demo

Modal title

Also from this source

HumanCo Investments Sends Letter to the Board of Directors of Grove Collaborative

HumanCo Investments Sends Letter to the Board of Directors of Grove Collaborative

HumanCo Investments ("HCI"), which is affiliated with investors that own more than 5% of Grove Collaborative Holdings, Inc. (NYSE: GROV) ("Grove" or...

More Releases From This Source

Explore

Banking & Financial Services

Banking & Financial Services

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Supplementary Medicine

Supplementary Medicine

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.